Core Insights - The individual has extensive experience in risk management and financial analysis, with a strong educational background in applied risk management and relevant certifications [1] - The focus areas include risk management, financial analysis, data science, and the influence of economic factors on financial markets [1] - The motivation for writing is to provide actionable insights for investors by translating complex financial data into understandable analysis [1] Group 1 - The individual holds an MSc in Applied Risk Management from the University of Athens and has completed the ACA Certificate Level [1] - The professional background includes roles in assurance, financial analysis, and trade operations at leading firms such as EY, PwC, Alpha Bank, and the National Bank of Greece [1] - The approach to investing emphasizes data-driven analysis and long-term value creation [1] Group 2 - The individual aims to write on topics related to risk assessment, financial modeling, and stock analysis [1] - There is a commitment to providing informed analysis on market trends, risk management practices, and investment strategies [1]

Core Viewpoint - The C3.ai class action lawsuit alleges that the company and its executives misled investors regarding the company's revenue outlook and growth potential, particularly in relation to CEO Thomas M. Siebel's health concerns, which ultimately led to a significant drop in stock price following disappointing financial results [1][4][5]. Group 1: Lawsuit Details - The lawsuit is titled Liggett v. C3.ai, Inc., No. 25-cv-07129, and is pending in the Northern District of California, representing purchasers or acquirers of C3.ai securities [1]. - The lawsuit claims that C3.ai's optimistic reports on growth and profitability were misleading and overly reliant on the health of its CEO [4]. - On August 8, 2025, C3.ai announced disappointing preliminary financial results for Q1 of fiscal year 2026 and reduced its revenue guidance for the full fiscal year, attributing these issues to leadership reorganization and the CEO's health, resulting in a stock price drop of over 25% [5]. Group 2: Lead Plaintiff Process - The Private Securities Litigation Reform Act of 1995 allows any investor who purchased C3.ai securities during the Class Period to seek appointment as lead plaintiff, representing the interests of the class [6]. - The lead plaintiff is typically the investor with the greatest financial interest in the case and can select a law firm to litigate the lawsuit [6]. Group 3: About Robbins Geller - Robbins Geller Rudman & Dowd LLP is a leading firm in securities fraud and shareholder litigation, having secured over $2.5 billion for investors in 2024 alone [7]. - The firm has been ranked 1 in the ISS Securities Class Action Services rankings for four out of the last five years, indicating its prominence in the field [7].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of C3.ai, Inc. regarding a class action lawsuit due to allegations of misleading statements and concealment of material facts that negatively impacted the company's stock performance [1][2]. Summary by Relevant Sections Allegations - The complaint alleges that C3.ai's management provided overly positive statements while concealing significant issues, particularly the health of the CEO, which affected the company's ability to close deals [1]. - The company failed to execute its profit and growth potential due to these undisclosed challenges [1]. Financial Impact - On August 8, 2025, C3.ai announced disappointing preliminary financial results for Q1 of fiscal 2026 and reduced its revenue guidance for the full fiscal year 2026 [1]. - The stock price dropped from $22.13 per share on August 8, 2025, to $16.47 per share on August 11, 2025, marking a decline of approximately 25.58% in just one day [1]. Class Action Details - Shareholders who purchased shares during the specified class period (February 26, 2025, to August 8, 2025) are encouraged to register for the class action [2]. - The deadline for seeking lead plaintiff status is October 21, 2025, and there is no cost to participate in the case [2].

Core Viewpoint - A class action lawsuit has been filed against C3.ai, alleging that the company and its executives misled investors regarding its financial health and growth prospects, particularly in relation to CEO Thomas M. Siebel's health issues [1][2][3]. Summary by Relevant Sections Lawsuit Details - The lawsuit, titled Liggett v. C3.ai, Inc., claims that C3.ai provided overly optimistic revenue projections while downplaying risks associated with CEO Siebel's health [2]. - The class period for the lawsuit is from February 26, 2025, to August 8, 2025, with a lead plaintiff deadline set for October 21, 2025 [2][4]. Financial Impact - Following C3.ai's financial announcement on August 8, 2025, which revealed preliminary first-quarter results that did not meet expectations and a lowered revenue guidance for the fiscal year, the company's stock price dropped by over 25% [3]. Investigation Focus - The investigation is centered on whether C3.ai's public statements were misleading, particularly regarding the impact of CEO Siebel's health on the company's ability to achieve financial targets [5].

Core Viewpoint - A class action lawsuit has been filed against C3.ai, Inc. and its executives for alleged violations of the Securities Exchange Act of 1934, claiming misleading information regarding the company's revenue outlook and CEO's health concerns [1][4]. Group 1: Lawsuit Details - The lawsuit is titled Liggett v. C3.ai, Inc., No. 25-cv-07129 (N.D. Cal.) and aims to represent purchasers or acquirers of C3.ai securities [1]. - Allegations include that C3.ai's executives created a false impression of reliable revenue projections while downplaying risks associated with CEO Thomas M. Siebel's health [4]. - On August 8, 2025, C3.ai announced disappointing preliminary financial results for Q1 FY 2026 and reduced its revenue guidance for the full fiscal year, attributing these issues to leadership reorganization and the CEO's health, leading to a stock price drop of over 25% [5]. Group 2: Lead Plaintiff Process - The Private Securities Litigation Reform Act of 1995 allows any investor who purchased C3.ai securities during the Class Period to seek appointment as lead plaintiff [6]. - The lead plaintiff is typically the investor with the greatest financial interest and acts on behalf of all class members [6]. Group 3: About Robbins Geller - Robbins Geller Rudman & Dowd LLP is a leading law firm specializing in securities fraud and shareholder litigation, having recovered over $2.5 billion for investors in 2024 alone [7]. - The firm has been ranked 1 in securing monetary relief for investors in securities class action cases for four out of the last five years [7].

NEW YORK, Oct. 16, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of C3.ai, Inc. (NYSE: AI). Shareholders who purchased shares of AI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/c3-ai-inc-loss-submission-form-2/?id=172056&from=3 CLASS PERIOD: February 26, 2025 to August ...

Core Viewpoint - A class action lawsuit has been filed against C3.ai, alleging that the company and its executives misled investors regarding its financial health and growth prospects [1] Company Summary - The lawsuit targets C3.ai, an enterprise AI software company, and claims violations of the Securities Exchange Act of 1934 [1] - The suit was filed in the U.S. District Court for the Northern District of California [1] - Investors who suffered significant losses are urged to submit their claims [1]

Company Overview - Sandisk is valued at $18.6 billion and is known for creating, manufacturing, and distributing flash memory storage systems used in smartphones, cameras, computers, and data centers [5] - The stock has experienced a significant rise of over 288% since its relisting under the SNDK ticker earlier this year, driven by increased demand for high-performance data storage solutions for AI workloads [4] Financial Performance - Analysts expect Sandisk's revenue to increase by 22% to $8.9 billion, with earnings projected to rise by 119% to $6.55 per share [2] - For the full fiscal year 2025, Sandisk reported a 10% increase in revenue to $7.3 billion and a profit of $2.99 per share, compared to a loss of $3.46 per share in fiscal 2024 [3] Market Position and Competition - The competitive landscape in the flash memory market remains intense, with Micron dominating both the NAND and DRAM markets [2] - The demand for massive storage and memory capacities driven by AI models positions Sandisk as an appealing target for Big Tech firms developing or expanding AI data centers [3] Analyst Ratings - Wall Street rates Sandisk stock as a consensus "Moderate Buy," with 11 out of 18 analysts recommending a "Strong Buy," six recommending a "Hold," and one suggesting a "Strong Sell" [1] - The stock has surpassed its average analyst price target of $94.28, with a high price estimate of $150 implying an upside potential of 8% over the next 12 months [1]

Core Insights - C3.ai, Inc. emphasizes the significance of its Initial Production Deployment (IPD) model as a key driver for enterprise adoption and recurring revenue growth, having closed 28 new IPDs in Q1 FY26, totaling 374 active deployments [1][9] Summary by Sections IPD Model and Revenue - The IPD framework serves as a 3-6 month trial for clients to assess the C3 Agentic AI Platform's real-world performance before full-scale deployment, with subscription and prioritized engineering services (PES) constituting 98% of total sales in Q1 FY26 [2][9] - The model is expected to create long-term customer retention, although it incurs transitional costs, leading to a decrease in non-GAAP gross margin to 52% from 59% year-over-year due to increased upfront support and implementation costs [3] Customer Engagement and Partnerships - C3.ai's customer engagement is expanding, with partnerships with Nucor, HII, and Qemetica showcasing the platform's integration into critical operations, including supply chain optimization and defense readiness [4] - Collaborations with major cloud providers like Microsoft Azure, AWS, and Google Cloud accounted for approximately 90% of deal activity in Q1 FY26, highlighting the platform's growing market presence [4] Future Growth and Financial Guidance - The conversion rate from IPDs to recurring subscriptions is anticipated to be pivotal for C3.ai's next growth phase, with Q2 FY26 revenue guidance set between $72 million and $80 million, indicating a modest recovery [5] - The company currently has over 260 active IPDs and aims to convert pilot projects into long-term enterprise contracts, which could enhance sustainable growth if conversion rates improve [6] Stock Performance and Valuation - C3.ai's shares have decreased by 30.2% over the past three months, contrasting with a 4.4% decline in the industry, while other competitors like TaskUs and ServiceNow have also seen declines [7] - The company trades at a forward price-to-sales ratio of 8.28X, significantly lower than the industry average of 17.05X, with other industry players showing varying P/S ratios [10]

Core Viewpoint - C3.ai, Inc. has experienced significant stock volatility, with a 27.7% decline over the past three months, contrasting with a 5.9% increase in the S&P 500, indicating investor concerns about the company's financial performance and execution [1][2][20] Financial Performance - In the latest quarter, C3.ai reported a nearly 20% year-over-year revenue drop, missing expectations, and widening losses, primarily due to a decline in demonstration license sales and costly initial production deployments [6][7] - The Zacks Consensus Estimate for fiscal 2026 and 2027 indicates a projected loss per share of -1.33 and -1.02, respectively, with a year-over-year sales decline of 23.1% for fiscal 2026, followed by a growth of 12.6% in fiscal 2027 [16][17] Market Dynamics - The enterprise AI market is expanding, but C3.ai faces intense competition and customer hesitance in adopting large-scale AI projects, which creates headwinds for growth [9] - Despite strong partnerships with major cloud providers and defense clients, investor skepticism remains until consistent growth and profitability are demonstrated [9] Strategic Initiatives - C3.ai is focusing on strong partnerships and a large addressable market, emphasizing the demand for enterprise AI applications across various industries [10] - Recent contract wins and customer expansions, including partnerships with Nucor and the U.S. Army, are aimed at enhancing revenue stability [11][12] - The company is investing in new go-to-market strategies, such as the Strategic Integrator Program, to broaden its reach without bearing the full burden of direct sales [13][14] Leadership and Execution - Leadership changes are intended to improve execution, with a new CEO and reorganization of sales and services divisions expected to enhance coordination and customer outcomes [15] - Management remains optimistic about the refreshed structure and substantial cash reserves supporting long-term expansion [15] Valuation - C3.ai is currently priced at a discount relative to its industry, with a forward 12-month price-to-sales ratio of 8.44, significantly lower than peers like Palantir Technologies and Snowflake [18]